Rodney Hannington
Follow
Get notifications in MyBN when activity occurs.
Rodney Hannington
Non-Executive Director / EVE Health Group
Rodney Hannington has been working in marketing and services in consumer health and fast moving consumer goods for over 15 years. He has international experience across markets in Australia, China, Japan, South Korea, South East Asia, Middle East, Africa, Russia and Ukraine.
Mr Hannington has lived in Australia, China and Singapore whilst working and consulting with consulting firms in Asia, Mondelez and Novartis. He is a consumer health marketer with a network in the health and food industries, and has been involved in several company acquisitions and new product launches within China and Australia.
Mr Hannington has been a member of the Monash University Department of Marketing Industry Advisory Board since 2013 and has held a variety of board roles at ASX-listed companies, with a particular focus in the consumer health space.
Mr Hannington has lived in Australia, China and Singapore whilst working and consulting with consulting firms in Asia, Mondelez and Novartis. He is a consumer health marketer with a network in the health and food industries, and has been involved in several company acquisitions and new product launches within China and Australia.
Mr Hannington has been a member of the Monash University Department of Marketing Industry Advisory Board since 2013 and has held a variety of board roles at ASX-listed companies, with a particular focus in the consumer health space.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 243rd | Argenica Therapeutics | 43% | |
| 291st | INOVIQ | 33% | 109% |
| 720th | EVE Health Group | 0% | -25% |
| 949th | Zelira Therapeutics | -14% | -38% |
| 1657th | Sprintex | -63% | -28% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 140th |  | EVE Health Group | $2.7m |
| 150th | | Sprintex | $1.9m |
| 152nd |  | Argenica Therapeutics | $1.7m |
| 155th | | Zelira Therapeutics | $1.6m |
| 157th | | INOVIQ | $1.6m |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, EVE Health Group | 15 Jun 2022 |
| NEW ROLE: Non-Executive Chair, Lifespot Health | 03 Nov 2020 |
